Sanjiv Patel sold $872k of RLAY
President and CEO at Relay Therapeutics, Inc.. 48,199 shares at an average of $18.10, traded Oct 7, 2026, filed Oct 8, 2026.
Score components
This filing reached EDGAR on Oct 8, 2026, so its score and components open to free visitors on Oct 15, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-418096, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 7, 2026 | SOpen-market sale Common Stock10b5-1 | -48,199 | $18.10 | $872k | 471,301 | 6 d ago |
Related signals
Other insiders at Relay Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 15, 2026 | Relay Therapeutics, Inc. | Thomas Catinazzo Chief Financial Officer | $329k 17,717 shares | -14% | |
| 26Weak | Relay Therapeutics, Inc. | Donald A Bergstrom President, R&D | $162k 8,530 shares | -2% | |
| 37Weak | Relay Therapeutics, Inc. | Thomas Catinazzo Chief Financial Officer | $336k 17,717 shares | -13% | |
| 44Moderate | Relay Therapeutics, Inc. | Sanjiv Patel President and CEO | $913k 48,199 shares | -8% | |
| 19Weak | Relay Therapeutics, Inc. | Peter Rahmer See remarks | $90k 4,508 shares | -2% | |
| 57Moderate | Relay Therapeutics, Inc. | SVF Pauling (Cayman) Ltd owner | $116M 6,000,000 shares | -22% | |
| 37Weak | Relay Therapeutics, Inc. | Thomas Catinazzo Chief Financial Officer | $350k 17,717 shares | -11% | |
| 45Moderate | Relay Therapeutics, Inc. | Sanjiv Patel President and CEO | $980k 48,199 shares | -8% | |
| 41Moderate | Relay Therapeutics, Inc. | Donald A Bergstrom President, R&D | $42k 2,237 shares | -1% | |
| 42Moderate | Relay Therapeutics, Inc. | Thomas Catinazzo Chief Financial Officer | $27k 1,459 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.